You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

CLINICAL TRIALS PROFILE FOR INVERT SUGAR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for invert sugar

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT04470479 ↗ Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome Completed Federal University of São Paulo Phase 3 2005-03-01 The purpose of this study was to access the possible beneficial effects of oral use of pilocarpine in relieving signs and symptoms of patients with Sjogren's syndrome
NCT00896311 ↗ Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women Completed University of Calgary N/A 2003-03-01 Breech presentations (where a baby presents with feet or bottom down) have an increased risk of perinatal and neonatal complications, and are usually delivered by cesarean section. As an alternative, so that the baby can be delivered vaginally, an attempt can be made to turn the baby so that it is head down: this manoeuvre is called an external cephalic version (ECV). Drugs that relax the uterus (tocolytic agents) are sometimes used to help improve ECV success rates. Nitroglycerin is a tocolytic agent, but intravenous nitroglycerin has not been tested as an agent to help ECV. There is some suggestion that nitroglycerin may be more helpful in women who have not previously been pregnant (nulliparous women) than in women who have been pregnant more than once (multiparous women), and so we have planned two trials. This study is designed to answer the following questions for nulliparous women: Will administration of IV nitroglycerin for uterine relaxation improve ECV success rates? Will an increase in ECV success result in a decreased cesarean section rate?
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 2 of 2 entries

Clinical Trial Conditions for invert sugar

Condition Name

1110-0.100.10.20.30.40.50.60.70.80.911.1Breech PresentationComplication of PregnancyDry Eye[disabled in preview]
Condition Name for invert sugar
Intervention Trials
Breech Presentation 1
Complication of Pregnancy 1
Dry Eye 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

11110-0.100.10.20.30.40.50.60.70.80.911.1Dry Eye SyndromesPregnancy ComplicationsBreech PresentationSjogren's Syndrome[disabled in preview]
Condition MeSH for invert sugar
Intervention Trials
Dry Eye Syndromes 1
Pregnancy Complications 1
Breech Presentation 1
Sjogren's Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for invert sugar

Trials by Country

+
Trials by Country for invert sugar
Location Trials
Brazil 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for invert sugar

Clinical Trial Phase

50.0%50.0%0-0.100.10.20.30.40.50.60.70.80.911.1Phase 3N/A[disabled in preview]
Clinical Trial Phase for invert sugar
Clinical Trial Phase Trials
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

100.0%0-0.200.20.40.60.811.21.41.61.822.2Completed[disabled in preview]
Clinical Trial Status for invert sugar
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for invert sugar

Sponsor Name

trials000001111111University of CalgaryFederal University of São Paulo[disabled in preview]
Sponsor Name for invert sugar
Sponsor Trials
University of Calgary 1
Federal University of São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

100.0%0-0.200.20.40.60.811.21.41.61.822.2Other[disabled in preview]
Sponsor Type for invert sugar
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Invert Sugar: Clinical Trials, Market Analysis, and Projections

Introduction

Invert sugar, a sweetener derived from the chemical breakdown of sucrose, has been a subject of interest in both clinical and market contexts. Here, we delve into the clinical trials, market analysis, and projections for invert sugar, highlighting its health implications, market trends, and future outlook.

Clinical Trials and Health Implications

Effects on Glucose Metabolism and DNA Damage

A study on rats fed with a diet rich in invert sugar revealed significant alterations in glucose metabolism. The high consumption of invert sugar led to obesity, impaired glucose tolerance, and an increase in abdominal fat. This diet also induced primary DNA damage in blood cells, although it did not cause significant damage to the pancreas or liver[1].

Histopathological Findings

The study showed that rats fed with invert sugar presented with liver steatosis and enlarged pancreatic islets, indicating potential insulin resistance and hepatic lipogenesis. However, these changes were not statistically significant compared to the control group[1].

Oxidative Stress and DNA Damage

Despite the induction of primary DNA damage in blood cells, there was no increase in permanent DNA damage in the bone marrow or significant oxidative stress. This suggests that while invert sugar may have some adverse effects on glucose metabolism and DNA integrity, it does not lead to severe long-term genomic damage[1].

Market Analysis

Global Market Size and Growth

The global invert sugar market is estimated to be valued at USD 2.1 billion in 2024 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.6% until 2034, reaching USD 3.3 billion by the end of the forecast period[2][5].

Regional Market Trends

  • United States: Expected to exhibit a CAGR of 6.7% during the forecast period.
  • Germany: Anticipated to demonstrate a CAGR of 8.9%.
  • Japan: Projected to showcase a CAGR of 7.4%.
  • China: Expected to see a CAGR of 3.5%.
  • India: Anticipated to display a CAGR of 9.8%[2][5].

Key Drivers of Market Growth

Growing Demand for Natural Sweeteners

The increasing consumer preference for natural and healthier sweetening alternatives is a major driver. Invert sugar's natural fructose content and lower glycemic index make it attractive for health-conscious consumers and those managing diabetes[2][5].

Advancements in Production Technology

The shift from traditional acid extraction methods to enzymatic processes has significantly impacted the market. Enzymatic extraction is more cost-effective, environmentally friendly, and produces a higher quality product[2][5].

Rising Popularity of Clean-Label Products

The growing demand for natural and clean-label products is driving the sales of invert sugar. Its suitability for diabetic-friendly products and its role in extending the shelf life of food products further boost its market appeal[2][4].

Applications of Invert Sugar

Food and Beverage Industry

Invert sugar is widely used in the bakery and confectionery industries due to its higher sweetness and ability to preserve moisture in baked goods. It is also used in cough syrups and other medical formulations for its soothing properties[2][3][4].

Non-Food Applications

Beyond the food sector, invert sugar is being explored for use in cosmetics, oral care, and pharmaceuticals. Its natural humectant and antimicrobial characteristics make it an attractive ingredient for moisturizers, lotions, toothpastes, and mouthwashes. It also has potential as a drug carrier, improving drug stability and solubility[3].

Sustainability and Production Innovations

Enzymatic Production

The enzymatic extraction process, which requires low temperature and pH conditions, yields 100% sugar syrup and offers better taste. This method is not only healthier but also more cost-effective and environmentally friendly[2][5].

Focus on Sustainability

Manufacturers are increasingly adopting sustainable practices, which enhance their brand image and reduce production costs. This aligns with the growing consumer preference for environmentally friendly products, further boosting the demand for invert sugar[2][4].

Challenges and Opportunities

Pricing Pressures and Health Perceptions

Despite its promising prospects, the market for invert sugar remains moderately competitive, with demand subject to pricing pressures and health perceptions surrounding sugar consumption. Businesses need to focus on product innovation, strategic partnerships, and expanding into untapped regions to realize potential opportunities efficiently[4].

Emerging Opportunities

The growing niche market for organic invert sugar and the enhancement of production processes focused on sustainability present further opportunities. Collaborations between food technologists and ingredient manufacturers to develop invert sugar with varied functional benefits could lead to breakthroughs[4].

Key Takeaways

  • Invert sugar alters glucose metabolism and induces primary DNA damage but does not cause significant long-term genomic damage.
  • The global invert sugar market is projected to grow significantly, driven by demand for natural sweeteners, advancements in production technology, and the rising popularity of clean-label products.
  • Invert sugar has diverse applications in the food and beverage industry and is being explored for non-food uses such as cosmetics and pharmaceuticals.
  • Sustainability and innovative production methods are key factors influencing market growth.

FAQs

What are the health implications of consuming invert sugar?

Consuming invert sugar can lead to impaired glucose tolerance, obesity, and primary DNA damage in blood cells, although it does not cause significant damage to the pancreas or liver.

What is the current market size of the invert sugar market?

The global invert sugar market is estimated to be valued at USD 2.1 billion in 2024.

What are the key drivers of the invert sugar market growth?

The key drivers include growing demand for natural sweeteners, advancements in production technology, and the rising popularity of clean-label products.

What are the main applications of invert sugar?

Invert sugar is widely used in the bakery and confectionery industries, as well as in cough syrups and other medical formulations. It is also being explored for use in cosmetics, oral care, and pharmaceuticals.

How is the production of invert sugar evolving?

The production of invert sugar is shifting from traditional acid extraction methods to enzymatic processes, which are more cost-effective, environmentally friendly, and produce a higher quality product.

What are the challenges facing the invert sugar market?

The market faces challenges such as pricing pressures and health perceptions surrounding sugar consumption, but opportunities lie in product innovation, strategic partnerships, and expanding into untapped regions.

Sources

  1. Invert sugar induces glucose intolerance but does not cause injury to the pancreas or liver in rats. SciELO.
  2. Invert Sugar Market Share, Trends & Forecast by 2034 | FMI. Future Market Insights.
  3. Invert Sugar Market Size, Share | Global Growth Report [2032]. Fortune Business Insights.
  4. Invert Sugar Market by Nature, End-Use Industry - GII Research. GII Research.
  5. Invert Sugar Market to Reach New Heights with Increasing Demand from Food & Beverage Industry. Accesswire.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.